Avanos Medical, Inc.
NYSE:AVNS
19.49 (USD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 87.7 | 127.7 | 118.5 | 111.5 | 205.3 | 384.5 | 219.7 | 113.7 | 129.5 | 149 | 44.1 | 47.9 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 87.7 | 127.7 | 118.5 | 111.5 | 205.3 | 384.5 | 219.7 | 113.7 | 129.5 | 149 | 44.1 | 47.9 |
| Net Receivables
| 142.8 | 167.9 | 131.2 | 167.9 | 163.8 | 150.5 | 203 | 190.1 | 224.7 | 233.9 | 203.3 | 183.7 |
| Inventory
| 163.2 | 190.3 | 150.3 | 168.9 | 145.9 | 121.4 | 91.1 | 272.5 | 303.2 | 283.1 | 285.6 | 301.7 |
| Other Current Assets
| 93.3 | 13.9 | 18.6 | 18.9 | 23.5 | 57.2 | 14.4 | 17.2 | 18.6 | 16.8 | 52.1 | 60.4 |
| Total Current Assets
| 487 | 499.8 | 418.6 | 467.2 | 538.5 | 713.6 | 1,160.7 | 593.5 | 676 | 684.9 | 585.1 | 593.7 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 144 | 194.5 | 206.7 | 223.6 | 248.5 | 154.1 | 109.9 | 260.8 | 279.5 | 277.8 | 324.9 | 325.7 |
| Goodwill
| 796.1 | 819.4 | 801.6 | 802.5 | 800.9 | 783.6 | 764.7 | 1,029 | 945.2 | 1,426.1 | 1,430.1 | 1,434.1 |
| Intangible Assets
| 239.5 | 251 | 141.2 | 157.7 | 184.3 | 168.2 | 148.9 | 169.8 | 82.6 | 108.3 | 141.2 | 176.8 |
| Goodwill and Intangible Assets
| 1,035.6 | 1,070.4 | 942.8 | 960.2 | 985.2 | 951.8 | 913.6 | 1,198.8 | 1,027.8 | 1,534.4 | 1,571.3 | 1,610.9 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.1 | 0 | 0 |
| Tax Assets
| 6.5 | 4.6 | 10 | 10 | 16.1 | 6.3 | 7.6 | 15.1 | 14.9 | 2.1 | 0 | 0 |
| Other Non-Current Assets
| 19.3 | 17.6 | 16.5 | 11.8 | 11.3 | 7.6 | 4.1 | 3.6 | 2 | 30.5 | 2.7 | 3.9 |
| Total Non-Current Assets
| 1,205.4 | 1,287.1 | 1,176 | 1,205.6 | 1,261.1 | 1,119.8 | 1,035.2 | 1,478.3 | 1,324.2 | 1,842.7 | 1,898.9 | 1,940.5 |
| Total Assets
| 1,692.4 | 1,786.9 | 1,594.6 | 1,672.8 | 1,799.6 | 1,833.4 | 2,195.9 | 2,071.8 | 2,000.2 | 2,527.6 | 2,484 | 2,534.2 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 56.3 | 67.9 | 56.4 | 67.6 | 83 | 169.9 | 171.2 | 173.1 | 163.2 | 168.7 | 118.5 | 102.2 |
| Short Term Debt
| 34.2 | 19 | 14.7 | 15.5 | 14.7 | 0 | 39.8 | 0 | 0 | 3.9 | 11.9 | 75.9 |
| Tax Payables
| 16.7 | 21.2 | 3 | 2.7 | 3.2 | 6.5 | 6.8 | 7.2 | 15.3 | 23.4 | 12.2 | 20.7 |
| Deferred Revenue
| 32.2 | 0 | 0 | 0 | 0 | 0 | 144.9 | 0 | 0 | 23.4 | 12.2 | 20.7 |
| Other Current Liabilities
| 127.4 | 9.8 | 8.7 | 12.9 | 28.6 | -82 | -144.1 | -29 | -26.5 | -32.1 | 37.1 | 37.4 |
| Total Current Liabilities
| 234.6 | 185.8 | 139.2 | 166.3 | 212.5 | 264.3 | 389.8 | 324.4 | 315.2 | 356 | 310.4 | 359.1 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 187.7 | 261 | 172.8 | 233.3 | 310.7 | 247.7 | 541.1 | 579 | 578.1 | 632.3 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 14.6 | 0 | 0 | -27.9 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 23.8 | 25.4 | 9.6 | 5.7 | 0 | 4.4 | 17.8 | 35.8 | 23.8 | 27.9 | 90.5 | 96.4 |
| Other Non-Current Liabilities
| 10 | 23.5 | 9.1 | 11 | 11.2 | 19.8 | 17.2 | 30.1 | 27.8 | 48.1 | 4 | 23 |
| Total Non-Current Liabilities
| 221.5 | 309.9 | 191.5 | 250 | 321.9 | 271.9 | 590.7 | 644.9 | 629.7 | 680.4 | 94.5 | 119.4 |
| Total Liabilities
| 456.1 | 495.7 | 330.7 | 416.3 | 534.4 | 536.2 | 980.5 | 969.3 | 944.9 | 1,036.4 | 404.9 | 478.5 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 2,098.7 | 2,045.6 |
| Retained Earnings
| -314.9 | -253.1 | -310.3 | -315.5 | -288.3 | -242.4 | -299.9 | -379.2 | -419 | 7.3 | 0 | 0 |
| Accumulated Other Comprehensive Income/Loss
| -27 | -35.8 | -33.8 | -28.1 | -32 | -33.7 | -31.3 | -50.1 | -43.2 | -19.1 | -19.6 | 10.1 |
| Other Total Stockholders Equity
| 1,577.7 | 1,579.6 | 1,607.5 | 1,599.6 | 1,585 | 1,572.8 | 1,546.1 | 1,531.3 | 1,517 | 1,502.5 | 0 | 0 |
| Total Shareholders Equity
| 1,236.3 | 1,291.2 | 1,263.9 | 1,256.5 | 1,265.2 | 1,297.2 | 1,215.4 | 1,102.5 | 1,055.3 | 1,491.2 | 2,079.1 | 2,055.7 |
| Total Equity
| 1,236.3 | 1,291.2 | 1,263.9 | 1,256.5 | 1,265.2 | 1,297.2 | 1,215.4 | 1,102.5 | 1,055.3 | 1,491.2 | 2,079.1 | 2,055.7 |
| Total Liabilities & Shareholders Equity
| 1,692.4 | 1,786.9 | 1,594.6 | 1,672.8 | 1,799.6 | 1,833.4 | 2,195.9 | 2,071.8 | 2,000.2 | 2,527.6 | 2,484 | 2,534.2 |